WASHINGTON, D.C. — In his first address to the nation since declaring victory, President-elect Joe Biden warned that widespread distribution of a COVID-19 vaccine was still months away, and he implored Americans to wear masks to contain the spread of the virus as the nation headed into a “dark winter” that could see hundreds of thousands of more deaths.
Biden, whose promise to bring competence to the federal government’s pandemic response was a central theme of his campaign, also announced he had appointed an advisory board Monday of top public health experts to guide his transition team’s COVID-19 planning.
“We are still facing a very dark winter,” Biden said in his public remarks, which followed a private briefing from the new advisory board. The president-elect, speaking hours after Pfizer Inc. announced promising progress in the development of a vaccine, warned Americans that wide distribution was not imminent.
“It’s clear that this vaccine, even if approved, will not be available for many months to come,” he said. “There is a need for bold action.
“A mask remains the most potent weapon against the virus” until a vaccine becomes widely available, Biden said. “Today’s news does not change that urgent reality.
“It doesn’t matter who you voted or where you stood before election. It doesn’t matter your party, your point of view. We can save tens of thousands of lives just in the next few months.
“Maybe it would save the life of a person who stocks the shelf at your local grocery store. Maybe it saves the life of a member of your place of worship. Maybe it saves the life of one of your children’s teachers. Maybe it saves your life,” he said.
“So, please, I implore you: Wear a mask.”
The remarks contrasted sharply with the approach to the pandemic of President Donald Trump, who has largely ignored his COVID-19 task force, has mocked mask-wearing, and has suggested vaccine distribution could happen by year’s end, contradicting the administration’s own public health experts.
The president-elect had earlier considered a national mask mandate, but there was no mention of such a mandate — which may be beyond the scope of the federal government’s authority — in Monday’s remarks.
The remarks and the unveiling of the advisory board came as the first public act of the Biden-Harris transition, signaling the urgency of the issue and its importance in propelling Biden to the White House.
The new advisory board will be led by three prominent Biden advisers — former Food and Drug Administration Commissioner David Kessler; former Surgeon General Vivek Murthy; and Marcella Nunez-Smith, an associate professor of internal medicine, public health and management at Yale University.
Many of the task force members played major roles in the last two Democratic administrations.
Scientists and public health leaders say that, in addition to battling the pandemic, another of Biden’s main challenges will be rebuilding trust in federal health agencies such as the Food and Drug Administration and the Centers for Disease Control and Prevention, both of which have been subject to intense political meddling under Trump.
Several task force members have been highly critical of the Trump administration’s response to the pandemic, including Rick Bright, an immunologist who directed the Biomedical Advanced Research and Development Authority but was pushed out earlier this year after clashing with Trump administration officials, whom he accused of ignoring warnings about the crisis.
The appointments come as the virus continues to surge, increasing its spread in at least 40 states. Some prominent Trump administration officials have also recently come down with COVID-19, including White House chief of staff Mark Meadows and Housing Secretary Ben Carson.
The new board is intended to guide the incoming administration’s response. It will be consulting with state and local officials to gauge public-health steps needed to bring the virus under control, Biden campaign officials said. The board will also focus on racial and ethnic disparities in how, where and how quickly the virus is spreading.
Other members of the board are:
■ Luciana Borio, a vice president at In-Q-Tel.
■ Ezekiel J. Emanuel, an oncologist and vice provost for Global Initiatives and chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania.
■ Atul Gawande, a professor of surgery at Brigham and Women’s Hospital and at Harvard Medical School.
■ Celine Gounder, a clinical assistant professor at the NYU Grossman School of Medicine.
■ Julie Morita, executive vice president of the Robert Wood Johnson Foundation.
■ Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota.
■ Loyce Pace, executive director and president of Global Health Council.
■ Robert Rodriguez, a professor of emergency medicine at UC San Francisco School of Medicine.
■ Eric Goosby, a professor of medicine at UC San Francisco School of Medicine.
